Use of effect size to determine optimal dose of duloxetine in major depressive disorder

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: 1994. Bech, 2002, Measurement issues, 25 Bech, 2002, Citalopram dose–response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression, Psychopharmacology, 163, 20, 10.1007/s00213-002-1147-6 Berney, 2005, Dose–response relationship of recent antidepressants in the short-term treatment of depression, Dialog in Clinical Neuroscience, 7, 249, 10.31887/DCNS.2005.7.3/pberney Danish University Antidepressant Group (DUAG), 1999, Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics, Clinical Pharmacology Therapeutics, 66, 152, 10.1016/S0009-9236(99)90053-X Detke, 2002, Duloxetine, 60mg once daily, for major depressive disorder: A randomized double-blind placebo-controlled trial, Journal of Clinical Psychiatry, 63, 308, 10.4088/JCP.v63n0407 Detke, 2002, Duloxetine, 60mg once daily dosing versus placebo in the acute treatment of major depression, Journal of Psychiatric Research, 36, 383, 10.1016/S0022-3956(02)00060-2 Detke, 2004, Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial, European Neuropsychopharmacology, 14, 457, 10.1016/j.euroneuro.2004.01.002 Dunner, 2005, Clinical consequences of initial duloxetine dosing strategies: comparison of 30 and 60mg QD starting doses, Current Therapeutic Research, 66, 1, 10.1016/j.curtheres.2005.12.003 Fabre, 1995, Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo, Biological Psychiatry, 38, 592, 10.1016/0006-3223(95)00178-8 Faries, 2000, The responsiveness of the Hamilton Depression Rating Scale, Journal of Psychiatric Research, 34, 3, 10.1016/S0022-3956(99)00037-0 Feighner, 1999, Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression, Journal of Clinical Psychiatry, 60, 824, 10.4088/JCP.v60n1204 Gleser, 2000 Goldstein, 2002, Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial, Journal of Clinical Psychiatry, 63, 225, 10.4088/JCP.v63n0309 Goldstein, 2004, Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine, Journal of Clinical Psychopharmacology, 24, 389, 10.1097/01.jcp.0000132448.65972.d9 Hamilton, 1960, A rating scale for depression, Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 Hamilton, 1967, Development of a rating scale for primary depressive illness, British Journal of Social Clinical Psychiatry, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x Hedges, 1985 Khan, 2003, Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: An analysis of the food and drug administration summary basis of approval reports, Neuropsychopharmacology, 28, 552, 10.1038/sj.npp.1300059 Mendels, 1999, Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia, Depression and Anxiety, 9, 54, 10.1002/(SICI)1520-6394(1999)9:2<54::AID-DA2>3.0.CO;2-T Nemeroff, 2002, Duloxetine for the treatment of major depressive disorder, Psychopharmacology Bulletin, 36, 106 Perahia, 2006, Duloxetine in the prevention of relapse of major depressive disorder: a double-blind, placebo-controlled study, British Journal of Psychiatry, 188, 10.1192/bjp.188.4.346 Sharma, 2000, Pharmacokinetics and safety of duloxetine, a dual-serotonin and norepinephrine reuptake inhibitor, Journal of Clinical Pharmacology, 40, 161, 10.1177/00912700022008810 Simpson, 1976, Two dosages of imipramine in hospitalized endogenous and neurotic depressives, Archives of General Psychiatry, 33, 1093, 10.1001/archpsyc.1976.01770090083008 Tran P, Lu Y, Martynov O, Detke, M. Safety and tolerability of duloxetine versus paroxetine. In: Poster presented at the American Psychiatric Association 2003, San Francisco, CA, 17–22 May. Wernicke, 1987, Fixed dose fluoxetine therapy for depression, Psychopharmacology Bulletin, 23, 164 Westanmo, 2005, Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor, American Journal of Health-System Pharmacy, 62, 2481, 10.2146/ajhp050006